Sains Malaysiana 51(4)(2022): 1167-1179

http://doi.org/10.17576/jsm-2022-5104-18

 

Protocatechuic Acid Induces Apoptosis in Human Osteosarcoma Cells by Regulating P13K/AKT/ROS Pathway

(Asid Protokatekuik Mengaruh Apoptosis dalam Sel Osteosarkoma Manusia dengan Mengawal Laluan P13K/AKT/ROS)

 

QIYUAN MEI, XIAOHU CHEN & WEI LIU*

 

Department of Orthopedics, Jingzhou Hospital of Traditional Chinese Medicine, Jingzhou, Hubei, China, 434000


† These two authors (Giyuan Mei and Xiaohu Chen) contributed to this work equally

 

Received: 14 July 2021/ Accepted: 3 September 2021

 

Abstract

Previous investigations have demonstrated that protocatechuic acid (PCA) provides anti-tumour properties in different tumour cell types. It does, however, have an unknown cause on osteosarcoma cells. In this investigation, the underlying mechanism of the effect of PCA on osteosarcoma cells (MNNG or HOS) was investigated and established. The viability of the cell was assessed with the MTT test. Acridine orange/ethidium bromide staining and Western blot analysis were conducted for assessment of cell apoptosis. Western blot analysis was identified for cell cycle progression. In addition to establishing the above findings, the Western blot analysis demonstrated that PCA mediated osteosarcoma cellular apoptosis by triggering the apoptotic pathway of Caspase-9. Additionally, we found that PCA considerably stimulated osteosarcoma cell apoptosis and arrest of cell cycle proliferation by controlling a pathway involving P13K/Akt/ROS signalling. In short, we observed that PCA prevented the advancement of osteosarcoma through the stimulation of apoptosis in osteosarcoma cells. The mechanism underlying this study also showed that PCA generated effective anti-tumour activity on osteosarcoma cells by controlling the signalling pathways of P13K/Akt/ROS.

 

Keywords: Caspase-9; MTT; osteosarcoma; protocatechuic acid; western blot

 

Abstrak

Kajian terdahulu telah menunjukkan bahawa asid protokatekuik (PCA) memberikan sifat anti-tumor dalam jenis sel tumor yang berbeza. Walau bagaimanapun, ia mempunyai punca yang tidak diketahui pada sel osteosarkoma. Dalam kajian ini, mekanisme asas kesan PCA pada sel osteosarkoma (MNNG atau HOS) telah dikaji dan ditubuhkan. Daya maju sel telah dinilai dengan ujian MTT. Pewarnaan akridina oren/etidium bromida dan analisis pemblotan Western telah dijalankan untuk penilaian apoptosis sel. Analisis pemblotan Western telah dikenal pasti untuk perkembangan kitaran sel. Di samping memulakan penemuan di atas, analisis pemblotan Western menunjukkan bahawa PCA memediasi apoptosis sel osteosarkoma dengan mencetuskan laluan apoptosis Caspase-9. Di samping itu, kami mendapati bahawa PCA banyak merangsang apoptosis sel osteosarkoma dan penangkapan percambahan kitaran sel dengan mengawal laluan yang melibatkan isyarat P13K/Akt/ROS. Ringkasnya, kami memerhatikan bahawa PCA menghalang kemajuan osteosarkoma melalui rangsangan apoptosis dalam sel osteosarkoma. Mekanisme yang mendasari kajian ini juga menunjukkan bahawa PCA menjana aktiviti anti-tumor yang berkesan pada sel osteosarkoma dengan mengawal laluan isyarat P13K/Akt/ROS.

 

Kata kunci: Asid protokatekuik; caspase-9; MTT; osteosarkoma; pemblotan Western

 

REFERENCES

Bai, Y-N., Yu, Z-Y., Luo, L-X., Yi, J., Xia, Q-J. & Yong, Z. 2014. MicroRNA-21 accelerates hepatocyte proliferation in vitro via PI3K/Akt signaling by targeting PTEN. Biochemical and Biophysical Research Communications 443(3): 802-807.

Bajpai, J., Chandrasekharan, A., Talreja, V., Simha, V., Chandrakanth, M.V., Rekhi, B., Khurana, S., Khan, A., Vora, T., Ghosh, J., Banavali, S.D. & Gupta, S. 2017. Outcomes in non-metastatic treatment-naive extremity osteosarcoma patients treated with a novel non-high dose methotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'. European Journal of Cancer 85: 49-58.

Chang, L., Shrestha, S., LaChaud, G., Scott, M.A. & James, A.W. 2015. Review of microRNA in osteosarcoma and chondrosarcoma. Medical Oncology 32(172): 1-7.

Chao, C.C., Hou, S.M., Huang, C.C., Hou, C.H., Chen, P.C. & Liu, J.F. 2017. Plumbagin induces apoptosis in human osteosarcoma through ROS generation, endoplasmic reticulum stress and mitochondrial apoptosis pathway. Molecular Medicine Reports 16(4): 5480-5488.

Chen, K., Ren, Q., Han, X.R., Zhang, X.N., Wei, B. & Bai, X.Z. 2016. Imatinib mesylate induces mitochondria-dependent apoptosis and inhibits invasion of human pigmented villonodular synovitis fibroblast-like synovial cells. Oncology Reports 35(1): 197-204.

Chou, A.J., Geller, D.S. & Gorlick, R. 2008. Therapy for osteosarcoma. Pediatric Drugs 10(5): 315-327.

Endo-Munoz, L., Cumming, A., Sommerville, S., Dickinson, I. & Saunders, N.A. 2010. Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone. British Journal of Cancer 103(1): 73-81.

Guttenplan, J.B., Chen, K.M., Sun, Y.W., Kosinska, W., Zhou, Y., Kim, S.A., Sung, Y., Gowda, K., Amin, S., Stoner, G.D. & El-Bayoumy, K. 2016. Effects of black raspberry extract and protocatechuic acid on carcinogen-DNA adducts and mutagenesis, and oxidative stress in rat and human oral cells. Cancer Prevention Research 9(8): 704-712.

Han, L., Liu, B., Jiang, L., Liu, J. & Han, S. 2016. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha. Tumor Biology 37(10): 13205-13214.

Heymann, M.F., Brown, H.K. & Heymann, D. 2016. Drugs in early clinical development for the treatment of osteosarcoma. Expert Opinion on Investigational Drugs 25(11): 1265-1280.

Kim, K., Bae, O.N., Lim, K.M., Noh, J.Y., Kang, S., Chung, K.Y. & Chung, J.H. 2012. Novel antiplatelet activity of protocatechuic acid through the inhibition of high shear stress-induced platelet aggregation. Journal of Pharmacology and Experimental Therapeutics 343(3): 704-711.

Kim, Y.S., Seo, H.W., Lee, M.H., Kim, D.K., Jeon, H. & Cha, D.S. 2014. Protocatechuic acid extends lifespan and increases stress resistance in Caenorhabditis elegansArchives of Pharmacal. Research 37(2): 245-252.

Li, J., Sharkey, C.C. & King, M.R. 2015. Piperlongumine and immune cytokine TRAIL synergize to promote tumor death. Scientific Reports 5(1): 1-12.

Lin, H.H., Chen, J.H., Chou, F.P. & Wang, C.J. 2011. Protocatechuic acid inhibits cancer cell metastasis involving the down‐regulation of Ras/Akt/NF‐κB pathway and MMP‐2 production by targeting RhoB activation. British Journal of Pharmacology 162(1): 237-254.

Lin, H.H., Chen, J.H., Huang, C.C. & Wang, C.J. 2007. Apoptotic effect of 3, 4‐dihydroxybenzoic acid on human gastric carcinoma cells involving JNK/p38 MAPK signaling activation. International Journal of Cancer 120(11): 2306-2316.

Lv, C., Hao, Y., Han, Y., Zhang, W., Cong, L., Shi, Y. & Tu, G. 2016. Role and mechanism of microRNA-21 in H2O2-induced apoptosis in bone marrow mesenchymal stem cells. Journal of Clinical Neuroscience 27: 154-160.

Raj, L., Ide, T., Gurkar, A.U., Foley, M., Schenone, M., Li, X., Tolliday, N.J., Golub, T.R., Carr, S.A., Shamji, A.F. & Stern, A.M. 2011. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475(7355): 231-234.

Robl, B., Pauli, C., Botter, S.M., Bode-Lesniewska, B. & Fuchs, B. 2015. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy. BMC Cancer 15(1): 1-12.

Salganik, R.I., Albright, C.D., Rodgers, J., Kim, J., Zeisel, S.H., Sivashinskiy, M.S. & Van Dyke, T.A. 2000. Dietary antioxidant depletion: Enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice. Carcinogenesis 21(5): 909-914.

Semaming, Y., Pannengpetch, P., Chattipakorn, S.C. & Chattipakorn, N. 2015. Pharmacological properties of protocatechuic acid and its potential roles as complementary medicine. Evidence-Based Complementary and Alternative Medicine 2015: 593902.

Srinivasulu, C., Ramgopal, M., Ramanjaneyulu, G., Anuradha, C.M. & Kumar, C.S. 2018. Syringic acid (SA) - A review of its occurrence, biosynthesis, pharmacological and industrial importance. Biomedicine & Pharmacotherapy 108: 547-557.

Tanaka, T., Kojima, T., Kawamori, T. & Mori, H., 1995. Chemoprevention of digestive organs carcinogenesis by natural product protocatechuic acid. Cancer 75(S6): 1433-1439.

Tsao, S.M., Hsia, T.C. & Yin, M.C. 2014. Protocatechuic acid inhibits lung cancer cells by modulating FAK, MAPK, and NF-κ B pathways. Nutrition and Cancer 66(8): 1331-1341.

Tseng, T.H., Kao, T.W., Chu, C.Y., Chou, F.P., Lin, W.L. & Wang, C.J. 2000. Induction of apoptosis by hibiscus protocatechuic acid in human leukemia cells via reduction of retinoblastoma (RB) phosphorylation and Bcl-2 expression. Biochemical Pharmacology 60(3): 307-315.

Tu, P., Huang, Q., Ou, Y., Du, X., Li, K., Tao, Y. & Yin, H. 2016. Aloe-emodin-mediated photodynamic therapy induces autophagy and apoptosis in human osteosarcoma cell line MG-63 through the ROS/JNK signaling pathway. Oncology Reports 35(6): 3209-3215.

Villegas Rubio, J.A., Cacciavillano, W., Rose, A., Zubizarreta, P. & Scopinaro, M. 2017. Ambulatory high-dose methotrexate administration in pediatric osteosarcoma patients at a single institution in Argentina. Journal of Pediatric Hematology/Oncology 39(7): 349-352.

Wang, H., Sun, N., Li, X., Li, K., Tian, J. & Li, J. 2016. Diallyl trisulfide induces osteosarcoma cell apoptosis through reactive oxygen species-mediated downregulation of the PI3K/Akt pathway. Oncology Reports 35(6): 3648-3658.

Wang, H., Zhang, Q., Zhang, L., Little, P.J., Xie, X., Meng, Q., Ren, Y., Zhou, L., Gao, G., Quirion, R. & Zheng, W. 2012. Insulin-like growth factor-1 induces the phosphorylation of PRAS40 via the PI3K/Akt signaling pathway in PC12 cells. Neuroscience Letters 516(1): 105-109.

Wang, S.W., Deng, L.X., Chen, H.Y., Su, Z.Q., Ye, S.L. & Xu, W.Y. 2021. MiR-124 affects the apoptosis of brain vascular endothelial cells and ROS production through regulating PI3K/AKT signaling pathway. European Review for Medical and Pharmacological Sciences 25(14): 4647.

Xie, C., Yi, J., Lu, J., Nie, M., Huang, M., Rong, J., Zhu, Z., Chen, J., Zhou, X., Li, B. & Chen, H. 2018. N-acetylcysteine reduces ROS-mediated oxidative DNA damage and PI3K/Akt pathway activation induced by Helicobacter pylori infection. Oxidative Medicine and Cellular Longevity 2018: 1874985.

Xiong, X.D., Ren, X., Cai, M.Y., Yang, J.W., Liu, X. & Yang, J.M. 2016. Long non-coding RNAs: An emerging powerhouse in the battle between life and death of tumor cells. Drug Resistance Updates 26: 28-42.

Zhou, Z.W., Li, X.X., He, Z.X., Pan, S.T., Yang, Y., Zhang, X., Chow, K., Yang, T., Qiu, J.X., Zhou, Q. & Tan, J. 2015. Induction of apoptosis and autophagy via sirtuin1-and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells. Drug Design, Development and Therapy 9: 1511-1554.

 

*Corresponding author; email: 33557355@qq.com

 

 

previous